![]() |
|
|
Vol. 57, Issue 5, 948-953, May 2000
Unité de Régulation Enzymatique des Activités Cellulaires, Centre National de la Recherche Scientifique, Unité de Recherche Associée 1773 (B.S., R.B., F.A., D.D-B., M.V.), and Unité de Chimie Organique, Centre National de la Recherche Scientifique, Unité de Recherche Associée 2128, 558 (R.S., C.G.), Institut Pasteur, Paris, France
| |
Abstract |
|---|
|
|
|---|
The last step in the intracellular activation of antiviral nucleoside analogs is the addition of the third phosphate by nucleoside diphosphate (NDP) kinase resulting in the synthesis of the viral reverse transcriptase substrates. We have previously shown that dideoxynucleotide analogs and 3'-deoxy-3'-azidothymidine (AZT) as di- or triphosphate are poor substrates for NDP kinase. By use of protein fluorescence, we monitor the phosphotransfer between the enzyme and the nucleotide analog. Here, we have studied the reactivity of D4T (2',3'-dideoxy-2',3'-didehydrothymidine; stavudine) as di- (DP) or triphosphate (TP) at the pre-steady state. The catalytic efficiency of D4T-DP or -TP is increased by a factor of 10 compared with AZT-DP or -TP, respectively. We use an inactive mutant of NDP kinase to monitor the binding of a TP derivative, and show that the affinity for D4T-TP is in the same range as for the natural substrate deoxythymidine triphosphate, but is 30 times higher than for AZT-TP. Our results indicate that D4T should be efficiently phosphorylated after intracellular maturation of a prodrug into D4T-monophosphate.
| |
Introduction |
|---|
|
|
|---|
Nucleoside
analogs AZT and D4T are powerful anti-HIV drugs that are now generally
used in combination with 3TC
(
-L-2',3'-dideoxy-3'-thiocytidine) and either an
antiprotease or a non-nucleosidic reverse transcriptase inhibitor in
tri-therapy protocols (Foudraine et al., 1998
). The pharmacological
target of AZT and D4T is the HIV reverse transcriptase because both
analogs act as DNA chain terminators due to the lack of 3'-OH in their
ribose moiety. However, to exert their antiviral activity, the
nucleoside analogs must be activated into triphosphate derivatives by
cellular kinases. Intracellular accumulation of mono or diphospho
compounds due to kinetically limiting steps in this phosphorylation
pathway could be responsible for some of the toxic effects of the
drugs, in particular at the mitochondrial level (Zhu et al., 1998
). The
last step in this pathway is catalyzed by NDP kinase. Although this
enzyme is generally not specific for the base and accepts
deoxyribonucleotides, we showed that the phosphorylation of AZT-DP and
ddNDP by NDP kinase is very slow and could constitute a limiting step
in the overall phosphorylation pathway (Bourdais et al., 1996
;
Schneider et al., 1998b
).
NDP kinase catalyzes the phosphotransfer from NTP to NDP with the
transient phosphorylation of a histidine at the active site (Garces and
Cleland, 1969
). The X-ray structures of NDP kinases from several
species have been determined at high resolution (Williams et al., 1991
;
Dumas et al., 1992
; Chiadmi et al., 1993
; Webb et al., 1995
), showing
that both the subunit fold and structure of the active site are highly
conserved. The mode of nucleotide binding to the protein is different
from that of most kinases because the base makes no polar interactions
with the protein and is at the protein surface. The ribose and
phosphate moieties are located deeper inside the NDP kinase active
site, forming numerous bonds with a Mg2+ ion and
with protein side chains. The enzyme-nucleotide complex is also
stabilized by a hydrogen bond network between the 3'-OH of the sugar,
the
-phosphate, and two conserved residues of the active site, Lys16
and Asn119 (Tepper et al., 1994
).
All eukaryotic NDP kinases are hexamers made of identical 17-kDa
monomers. In humans, in whom five isoforms have been reported, the
major forms are NDPK-A and NDPK-B, which are encoded, respectively, by
the genes nm23-H1 and nm23-H2 and display 88%
amino acid identity. The other members of the family include
DR-nm23, involved in apoptosis (Venturelli et al., 1995
),
the mitochondrial nm23-H4 (Milon et al., 1997
), and
nm23-H5, found in testis germ cells but devoid of enzymatic
activity (Munier et al., 1998
). Human A and B enzymes present similar
kinetic parameters for natural substrates (Schaertl et al.,
1998
) as well as for a series of thymidine diphosphate derivatives (Gonin et al., 1999
). Both the structure and the kinetic parameters of the NDP kinase from the lower eukaryote
Dictyostelium discoideum (Dd-NDPK) are also very similar to
those of human NDPK-A or NDPK-B, and this has allowed us to use Dd-NDPK
as a reliable model for eukaryotic NDP kinases. The structure of
Dd-NDPK was also solved in the presence of ADP and
AlF3 which led to modeling of the transition
state and the catalytic mechanism (Xu et al., 1997a
).
NDP kinase has a very high turnover with
kcat around 1000 s
1
for "natural" ribo- or deoxyribonucleotides. The fluorescence properties of NDP kinases allowed us to monitor the degree of phosphorylation of the catalytic histidine (Deville- Bonne et al.,
1996
), and we have shown by steady-state enzymatic assays that AZT-TP
and ddTTP are poor substrates for NDP kinase, with a loss in catalytic
efficiency in the 104 to
105 range as compared with natural nucleotides
(Bourdais et al., 1996
). Using stopped-flow experiments, we showed that
this loss is due to a dramatic decrease in the phosphate transfer rate
between the analog and the enzyme (Schneider et al., 1998b
).
AZT and D4T are both thymidine analogs and are presumably
phosphorylated by the same cellular kinases. However, their patterns of
intracellular phosphorylation are not the same because, in particular,
D4T is phosphorylated to its 5'-monophosphate at a level 500-fold lower
than AZT is (Balzarini et al., 1989
; Gao et al., 1994
). In this work we
have used pre-steady-state and steady-state experiments to investigate
kinetic parameters of human NDPK-A with D4T-DP or D4T-TP as a
substrate. We show that D4T-DP is more easily phosphorylated by NDPK-A
than is AZT-DP. The use of an inactive mutant of Dd-NDPK allowed us to
investigate for the first time the binding of NTPs to NDP kinase in the
absence of catalysis. We show that D4T-TP binds to the NDP kinase
active site with an affinity similar to that of natural substrates,
whereas AZT-TP is a weaker ligand.
| |
Experimental Procedures |
|---|
|
|
|---|
Materials.
Natural nucleotides were from Roche Molecular
Biochemicals. The chemical synthesis of phosphoderivatives of
nucleoside analogs was as described previously (Bourdais et al., 1996
).
The double mutation F64W-H122G in Dd-NDPK was made by site-directed
mutagenesis according to the method of Kunkel (1985)
, with the
oligonucleotides 5'-GAAAGACCATGGTTCGGTGGTT-3'
and 5'-GAAACATCATCGGCGGTTCTGATTC-3' for the F64W
and H122G mutations, respectively. Altered bases as compared with the
wild-type sequence are bold underlined. The mutations were verified by
DNA sequencing.
Enzyme Purification.
Wild-type human NDPK-A was
overexpressed in Escherichia coli (BL21-DE3) by using
plasmid pJC20 (gift from M. Konrad) after induction for 5 h by 1 mM isopropylthiogalactoside when the culture reached
A600 nm
0.5. Cells were collected, washed
twice, and resuspended in extraction buffer (50 mM Tris-HCl, pH 8.0, 20 mM KCl, 1 mM EDTA, 5 mM MgCl2, and 1 mM DTE)
containing 1 mM phenylmethylsulfonyl fluoride. The cell extract was
diluted 2.5-fold with extraction buffer and centrifuged at
10,000g for 20 min at 4°C. The supernatant was treated by
0.15% Polymin P (BASF) to precipitate most of the nucleic
acids. After centrifugation at 10,000g for 15 min, the supernatant was loaded at pH 8.0 onto a POROS HQ column (PerSeptive Biosystems, Cambridge, MA; 2.6 × 12 cm) equilibrated in 50 mM Tris-HCl, pH 8.0, 1 mM EDTA, and 1 mM DTE. The recombinant enzyme was
separated from the E. coli NDP kinase by a linear KCl
gradient (0.02-1 M). Active fractions measured as in Lascu et al.
(1992)
were pooled, diluted 2-fold with 100 mM Bis-Tris, pH 6.0 and DTE 1 mM, and loaded onto a ceramic hydroxyapatite column (American International Chemical, 1.6 × 10 cm) equilibrated in 10 mM
potassium phosphate, pH 6.5, and 1 mM DTE. NDPK-A was eluted by a
linear potassium phosphate gradient (0.01-1 M). After concentration
and desalting by ultrafiltration in 50 mM Tris-HCl, pH 7.5, 1 mM DTE, and 20 mM KCl, the enzyme was extensively dialyzed against the same
buffer containing 50% glycerol and stored at
20°C. NDPK-A was > 97% pure as judged by SDS-PAGE. Wild-type and mutant Dd-NDPK were
overexpressed in E. coli (XL1-Blue) and purified as
previously described (Schneider et al., 1998a
). Enzyme concentration
expressed as 17-kDa subunits was determined either by the method of
Bradford (1976)
or by using an absorbance coefficient of
A280 = 1.238, 0.55, and 0.85 for a 1 mg/mL
solution of NDPK-A, Dd-NDPK, and the double mutant F64W-H122G,
respectively (Gill and Von Hippel, 1989
). F64W-H122G mutant NDP kinase
had no measurable NDP kinase activity but had a very slight ATPase
activity
(kcat/KM = 450 M
1 s
1).
Fluorometric Binding Studies.
The affinity of NDP and NTP
derivatives for NDP kinase was determined by following the variation of
the intrinsic fluorescence upon nucleotide binding as described in
Schneider et al. (1998b)
. The fluorescence of the F64W-H122G enzyme in
T1 buffer (50 mM Tris-HCl, 75 mM KCl, 5 mM
MgCl2, pH 7.5) was measured at 330 nm with
excitation at 310 nm (2-nm excitation slit and 4-nm emission slit).
Successive aliquots of nucleotide were added to a 1 µM enzyme
solution. The inner filter effect was negligible. Experimental binding
curves were fitted to a quadratic equation for ligand-protein curve
after correction for dilution. By using the double mutant with NTP, the
true NTP concentration was measured in order to take into account the
small residual ATPase activity. The correction was less than 2%.
Stopped-Flow Kinetic Experiments.
Stopped-flow kinetic
experiments were performed with a Hi-Tech DX2 microvolume stopped-flow
reaction analyzer equipped with a high intensity xenon lamp as
described (Schneider et al., 1998b
). The excitation wavelength was 304 nm, with a 2-mm excitation slit and a 320-nm cutoff filter at the
emission. Mixing was achieved in less than 2 ms. After mixing NDPK (1 µM) and NTP (10-500 µM) or phosphorylated NDPK and NDP, the
intrinsic protein fluorescence was recorded for 10 to 200 s. In
each experiment 400 pairs of data were recorded, and the data from
three to four identical experiments were averaged and fitted to a
number of nonlinear analytical equations using the software provided by
Hi-Tech. All curves fitted to single exponentials.
Analysis of Kinetic Results.
As previously described
(Schneider et al., 1998b
), the data were analyzed with the reaction
scheme:
|
(1) |
|
| |
Results |
|---|
|
|
|---|
Kinetics of D4T Phosphorylation and Dephosphorylation by NDP
Kinase.
The intrinsic fluorescence of NDP kinase decreases upon
phosphorylation of the catalytic histidine, providing a convenient signal for probing the state of phosphorylation of the enzyme (Schneider et al., 1998b
). Figure 1A
shows the time course of this fluorescence decrease when human NDPK-A
is mixed rapidly with different phosphodonors. Addition of D4T-TP
results in an exponential decrease in fluorescence leading to a plateau
which corresponds to the steady-state of the phosphorylation reaction. Each recorded fluorescence time course follows a single decay with no
evidence of lag, burst, or biphasicity. Whereas the amplitude of the
fluorescence change is almost constant, the constant of the exponential
representing the rate constant of the phosphorylation reaction is
linear with the concentration of the phosphodonor in the range 10 to
500 µM (Fig. 1B).
|
1
s
1) is 10 times faster than by AZT-TP
(CEphos = 75 M
1
s
1) and 30 times faster when compared
with ddTTP (CEphos = 20 M
1 s
1). Note that, even
for D4T, the values of CEphos are low
compared with natural nucleotides. Table 1 also shows that similar
results are obtained with Dd-NDPK, indicating that this protein can
serve as a model for the study of analog phosphorylation. ddTTP is, however, a slightly better substrate than AZT-TP, as previously shown
(Schneider et al., 1998b
|
|
Measure of the Affinity of NDP Kinase for NTP.
Up to now, all
previous affinity measurements of nucleotides for NDPK have been made
with NDP, as well as AZT-DP and ddNDP (Schneider et al., 1998b
),
because for NTP the
-phosphate hydrolysis is too fast. However
diphospho-compounds lead to the formation of "dead-end" complexes
that are not normally part of the reaction, and it would be important
to determine the true affinities of NDPK for its NTP substrates. To
adress this question, we combined two previously characterized single
mutations in the Dd-NDPK. The H122G mutation results in an inactive
protein because it is unable to autophosphorylate. Crystal structure of
the complex between the H122G enzyme and ADP...
Pi-Mg2+ shows that the mutation does not
affect the overall structure of the catalytic site (Admiraal et al.,
1999
). In contrast, the single mutant F64W, where the Phe 64 at the
entrance of the active site is substituted to a Trp residue, is fully
active. Moreover this Trp constitutes a fluorescent probe that is
sensitive to NDP nucleobase stacking (Schneider et al., 1998b
). Figure
2 (inset) shows the intrinsic
fluorescence of F64W-H122G mutant NDP kinase. Upon excitation at 310 nm, the fluorescence intensity of the mutant protein increases by 50%
upon any NTP and NDP addition.
|
|
| |
Discussion |
|---|
|
|
|---|
In this paper, we show that the DP and the TP forms of D4T are
considerably better substrates for NDP kinase than are AZT derivatives.
D4T-TP also has a high affinity toward HIV reverse transcriptase and
human DNA polymerase
(Ono et al., 1989
), possibly due to the
planarity of the glycone cycle resulting in a unique conformation of
the nucleotide, which allows the formation of a reaction complex with
DNA polymerase and participates in the formation of the transition
state (Krayevsky and Watanabe, 1998
). In contrast, the presence of an
azido group on the sugar moiety may restrict its mobility and prevent a
planar conformation from occurring within the catalytic cycle. In
agreement with this hypothesis, the deoxyribose is found C2'-endo in
AZT-DP (Xu et al., 1997b
), whereas it is C3'-endo for natural NDP
(Cherfils et al., 1994
; Morera et al., 1994
, 1995
). A precise
structural explanation for the different efficiencies of AZT and D4T
derivatives as substrates for NDP kinase is presently not available.
However, we hypothesize a role of the conserved Lys (K16 in Dd-NDPK,
K12 in NDPK-A) that participates in catalysis (Tepper et al., 1994
).
Indeed, the side chain of this lysine moves by more than 2.6Å upon
binding of the bulky azido group (Xu et al., 1997b
), and this probably
results in the poor phosphorylation of AZT-DP by NDP kinases. The
absence of steric hindrance in the D4T analog may leave the lysine in place, resulting in a better phosphorylation efficiency.
The three enzymes involved in the cellular phosphorylation pathway of
thymidine derivatives, i.e., TK, thymidylate kinase, and NDP kinase,
have very different efficiencies toward D4T and AZT (Balzarini et al.,
1989
). Whereas the critical steps in the AZT phosphorylation pathway
are the reactions catalyzed by thymidylate kinase (Lavie et al., 1997
)
and NDP kinase (Schneider et al., 1998b
), the pharmacological
activation of D4T is mostly dependent upon its phosphorylation in
D4T-MP (Balzarini et al., 1989
). In vitro studies also show that D4T is
a poor substrate for purified human TK1 and TK2 (Munch-Petersen et al.,
1991
). By using recombinant enzymes, we showed that, although D4T is a
poor substrate for TK from E. coli, D4T-MP is a good
substrate for E. coli thymidylate kinase (not shown). We
show here that the phosphorylation of D4T-DP by NDP kinase is 10 times
more efficient than that by AZT or ddNDPs. Our results highlight the
potential interest for designing a prodrug to deliver D4T-MP inside
cells to bypass the TK-dependent reaction step (Balzarini et al., 1996
;
Egron et al., 1998
). Because D4T is already known to present less
toxicity (Kaul et al., 1999
) and to elicit less resistance than AZT at
the reverse transcriptase level, a prodrug of D4T should be efficiently
phosphorylated after intracellular maturation into D4T-MP.
| |
Acknowledgments |
|---|
We thank Manuel Babolat for excellent technical assistance in purifications and stopped-flow experiments and Céline Costa for help in titrations. We also thank Manfred Konrad (Max Planck Institute, Göttingen, Germany) for the gift of plasmid, Ioan Lascu (Université Bordeaux II, France) for making results available before publication, and Joel Janin (LEBS, Gif sur Yvette, France) and Jeff Stock (Princeton University, Princeton, NJ) for stimulating discussions.
| |
Footnotes |
|---|
Received September 29, 1999; Accepted January 20, 2000
1 This work was supported by funds from Agence Nationale de la Recherche contre le SIDA, the Association de la Recherche sur le Cancer, and from SIDACTION. R. B. was recipient of a fellowship from Fondation de la Recherche Médicale. This work has been presented as a poster presentation at Gordon Research Conferences, Purines, pyrimidines and related substances, Salve Regina University, University of Rhode Island, Kingston, RI, July 4-9,1999, and at the 7th Symposium of the European Society for the Study of Purine & Pyrimidine Metabolism in Man, Gdansk, Poland, September 15-19, 1999.
2 Present address: Division of Signal Transduction Therapy, University of Dundee, UK.
Send reprint requests to: Dominique Deville-Bonne, Unité de Régulation Enzymatique des Activités Cellulaires, Institut Pasteur, 25 rue du Dr. Roux, 75724 Paris Cedex 15, France. E-mail: ddeville{at}pasteur.fr
| |
Abbreviations |
|---|
AZT, 3'-deoxy-3'-azidothymidine; DP, diphosphate; MP, monophosphate; TP, triphosphate; Dd-NDPK, Dictyostelium nucleoside diphosphate kinase; D4T, 2',3'-didehydro-2',3'-dideoxythymidine; ddTTP, 2',3'-dideoxythymidine triphosphate; ddNDP, 2',3'-dideoxynucleotide diphosphate; ddNTP, 2',3'-dideoxynucleotide triphosphate; NDP, nucleoside diphosphate; NDPK-A, human nucleoside diphosphate kinase type A; NTP, nucleoside triphosphate; PMSF, phenylmethylsulfonyl fluoride, TK, thymidine kinase; DTE, dithioerythritol.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. Basavapathruni and K. S. Anderson Reverse transcription of the HIV-1 pandemic FASEB J, December 1, 2007; 21(14): 3795 - 3808. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Hsu, R. Hu, G. E. Dutschman, G. Yang, P. Krishnan, H. Tanaka, M. Baba, and Y.-C. Cheng Comparison of the Phosphorylation of 4'-Ethynyl 2',3'-Dihydro-3'-Deoxythymidine with That of Other Anti-Human Immunodeficiency Virus Thymidine Analogs Antimicrob. Agents Chemother., May 1, 2007; 51(5): 1687 - 1693. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gallois-Montbrun, Y. Chen, H. Dutartre, M. Sophys, S. Morera, C. Guerreiro, B. Schneider, L. Mulard, J. Janin, M. Veron, et al. Structural Analysis of the Activation of Ribavirin Analogs by NDP Kinase: Comparison with Other Ribavirin Targets Mol. Pharmacol., March 1, 2003; 63(3): 538 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gallois-Montbrun, B. Schneider, Y. Chen, V. Giacomoni-Fernandes, L. Mulard, S. Morera, J. Janin, D. Deville-Bonne, and M. Veron Improving Nucleoside Diphosphate Kinase for Antiviral Nucleotide Analogs Activation J. Biol. Chem., October 11, 2002; 277(42): 39953 - 39959. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Krishnan, J.-Y. Liou, and Y.-C. Cheng Phosphorylation of Pyrimidine L-Deoxynucleoside Analog Diphosphates. KINETICS OF PHOSPHORYLATION AND DEPHOSPHORYLATION OF NUCLEOSIDE ANALOG DIPHOSPHATES AND TRIPHOSPHATES BY 3-PHOSPHOGLYCERATE KINASE J. Biol. Chem., August 23, 2002; 277(35): 31593 - 31600. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Schneider, A. Norda, A. Karlsson, M. Veron, and D. Deville-Bonne Nucleotide affinity for a stable phosphorylated intermediate of nucleoside diphosphate kinase Protein Sci., July 1, 2002; 11(7): 1648 - 1656. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Krishnan, Q. Fu, W. Lam, J.-Y. Liou, G. Dutschman, and Y.-C. Cheng Phosphorylation of Pyrimidine Deoxynucleoside Analog Diphosphates. SELECTIVE PHOSPHORYLATION OF L-NUCLEOSIDE ANALOG DIPHOSPHATES BY 3-PHOSPHOGLYCERATE KINASE J. Biol. Chem., February 8, 2002; 277(7): 5453 - 5459. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Selmi, J. Boretto, J.-M. Navarro, J. Sire, S. Longhi, C. Guerreiro, L. Mulard, S. Sarfati, and B. Canard The Valine-to-Threonine 75 Substitution in Human Immunodeficiency Virus Type 1 Reverse Transcriptase and Its Relation with Stavudine Resistance J. Biol. Chem., April 20, 2001; 276(17): 13965 - 13974. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||